【投资要点】截至2025Q1-3 对A 股医药企业最新发布的三季报数据汇总，461 家医药生物A 股上市公司2025 年前三季度营收为17876.4 亿元，同比降低2%，归母净利为1435.7 亿元，同比降低6.43%；单2025Q3 实现营业收入5936.9 亿元，同比增长0.51%；归母净利为419.4 亿元，同比降低0.95%。从前三季度业绩表现来看，医药板块收入端同比仍未改善，归母净利润端...
Source Link【投资要点】截至2025Q1-3 对A 股医药企业最新发布的三季报数据汇总，461 家医药生物A 股上市公司2025 年前三季度营收为17876.4 亿元，同比降低2%，归母净利为1435.7 亿元，同比降低6.43%；单2025Q3 实现营业收入5936.9 亿元，同比增长0.51%；归母净利为419.4 亿元，同比降低0.95%。从前三季度业绩表现来看，医药板块收入端同比仍未改善，归母净利润端...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.